NCT05219097View on ClinicalTrials.gov

The Specificity, Sensitivity and Clinical Correlation of CBA, RIPA and ELISA in Detecting AChR and MuSK IgG of Myasthenia Gravis

CompletedOBSERVATIONAL

Enrollment

2,663

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

September 30, 2022

Study Completion Date

December 31, 2022

Conditions

Detection Autoantibody of Myasthenia Gravis

Interventions

DIAGNOSTIC_TEST

CBA Assay

Comparsion of specificity, sensitivity and clinical correlation of CBA, ELISA and RIPA assay in autoantibodies detection of myasthenia gravis

Trial Locations (2)

30000

Tianjin Medical University General Hospital, Tianjin

100070

Beijing Tiantan Hospital, Beijing

All Listed Sponsors

lead

Tianjin Medical University General Hospital

OTHER

NCT05219097 - The Specificity, Sensitivity and Clinical Correlation of CBA, RIPA and ELISA in Detecting AChR and MuSK IgG of Myasthenia Gravis | Biotech Hunter | Biotech Hunter